Address: Kevin O’Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2,Ireland
Tel: 353-1-676 4971
Web: http://www.imb.ie/
The mission of the Irish Medicines Board (IMB) is
‘to protect and enhance public and animal health through the regulation of medicines, medical devices and healthcare products’
The objective of the IMB is to ensure in so far as possible, consistent with current medical and scientific knowledge, the quality, safety and efficacy of medicines available in Ireland and to participate in systems designed to do that throughout the European Union. Before a medicine can be authorised for use, an application must be made to the IMB and this must contain all of the necessary data supporting its quality, safety and efficacy.
The IMB is committed to the implementation and maintenance of a documented quality management system which is continually improved. The system is based on the requirements of the legislation, the regulatory system and ISO 9000:2000; it also takes into account guidelines, standards and best practices from Irish and international organisations.
Recent announcements from Ipsen and AbbVie of multimillion Euro investments into Irish manufacturing plants underline the Celtic nation’s continuing attractiveness to pharma multinationals. While an upcoming hike in Ireland’s famously…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million manufacturing investment; and a new report on…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life Sciences at Agility, discuss the company’s increased commitment to Ireland, their ongoing…
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC.…
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products. “Sales from…
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory solutions, discusses the changes that the Irish healthcare system is going through, and how they…
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile,…
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on…
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain portfolio, the innovation they are bringing as pain specialists to…
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
See our Cookie Privacy Policy Here